Valuing Research leads: Bioprospecting and the Conservation of Genetic Resources

By Gordon C. Rausser, Arthur A. Small. Journal of Political Economy, 2000

203 citations recorded by the source corpus.

Subfields: Economics and Econometrics, Management of Technology and Innovation

View Paper: https://www.semanticscholar.org/paper/20d348567c38fa2f3d925f1cf63177ff8563ed6f

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Economics and Econometrics

1. G. Atkinson
2. D. Pearce
3. S. Mourato
4. O. Mertz
5. S. Pagiola
6. Sven Wunder
7. Richard S. J. Tol
8. Cameron Hepburn

In Management of Technology and Innovation

1. D. Pearce

Citations in the corpus

• The Economic Value of Forest Ecosystems (2001, background): “…spot’ land areas ($ per hectare) Area Simpson et al. (1996) WTP of pharmaceutical companies Simpson & Craft (1996) ‘Social value’ of genetic material per ha Rausser & Small (1998) WTP of pharmaceutical companies Western Ecuador 20.6 2,888 9,177 Southwestern Sri Lanka 16.8 2,357 7,463 New Caledonia…”
• Valuation methods for environmental benefits in forestry and watershed investment projects. (2004, unknown): “In opposition, Rausser and Small (2000) demonstrate that this theory holds true only in the “degenerate” case in which no prior information is available.”
• Assessing the Economic Value of Ecosystem Conservation (2004, background): “…Barbier and others, 1995; Pearce and others, 2002), biodiversity for medicinal or industrial uses (Simpson and others, 1994; Barbier and Aylward, 1996; Rausser and Small, 2000), natural crop pollination (Ricketts and others, 2004), and cultural benefits (Pagiola, 1996; Navrud and Ready, 2002).”
• Ecosystem services and biodiversity in developing countries (2007, background): “The second group of studies focuses on the value of particular ecosystem goods and services, such as watershed services, carbon storage, non-timber forest products, recreation, and landscape beauty, biodiversity for medicinal or industrial uses, natural crop pollination and cultural beneWts (Pagiola”
• Cost-Benefit Analysis and the Environment: Recent Developments (2006, background): “Rausser and Small (2000) argue that the information value attached to a lead arises from the costs of search and the probability of a success, with the value of the successful drug being relatively unimportant.”